Blog
RSS FeedPosted by Michael Wonder on 28 Mar 2017
Roche withdraws submission for Avastin
28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...
Posted by Michael Wonder on 01 Mar 2016
Revised CADTH procedure for voluntary withdrawal of a submission
25 February 2016 - Effective for all submissions and resubmissions targeting the April 2016 CDEC meeting and onward, manufacturers will have ...